SCHEMBL17832308

SCHEMBL17832308

Cc1cc(N2CCN(c3ncc(C=O)cn3)CC2)ccc1F

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.46
ALDH1A1 P00352 4/20 0.40
GRM5 P41594 3/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
RXRA P19793 6/20 0.38
GRIN1 Q05586 6/20 0.38
GRIN2B Q13224 6/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A3 P47895 2/20 0.38
MAPT P10636 2/20 0.37
TSHR P16473 2/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17832258 0.74 DHFR (0.48) ALDH1A1SMN1; SMN2MAPT
SCHEMBL19627322 0.72 CHRNB2 (0.51) ALDH1A1KMT2ASMN1; SMN2MAPT
SCHEMBL16755649 0.72 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1MAPTTSHR
SCHEMBL12176444 0.71 HPGD (0.51) ALDH1A1KMT2AMEN1SMN1; SMN2MAPT
SCHEMBL17832326 0.71 KCNA5 (0.44) ALDH1A1KMT2ARXRAGRIN1GRIN2B
SCHEMBL3122946 0.70 ADRB1 (0.43) ALDH1A1KMT2AMEN1RXRAGRIN1
SCHEMBL18586416 0.70 RXRA (0.41) ALDH1A1KMT2ARXRAGRIN1GRIN2B
SCHEMBL25308181 0.69 TRIM24 (0.44) ALDH1A1SMN1; SMN2ALDH1A3MAPT
SCHEMBL1133951 0.69 TRIM24 (0.48) ALDH1A1SMN1; SMN2ALDH1A3MAPTMAPK1
SCHEMBL336067 0.69 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1SMN1; SMN2ALDH1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334927-A1 Nitroimidazole Compound, Preparation Method Therefor And Use Thereof In Drug Manufacturing SHANGHAI SUN-SAIL PHARMACEUTICAL SCIENCE & TECHNOLOGY CO., LTD. (CN) 2017-11-23 US disclosed
US-20170334927-A1 Nitroimidazole Compound, Preparation Method Therefor And Use Thereof In Drug Manufacturing SHANGHAI SUN-SAIL PHARMACEUTICAL SCIENCE & TECHNOLOGY CO., LTD. (CN) 2017-11-23 US disclosed
WO-2016091207-A1 NITROMIDAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF IN DRUG MANUFACTURING 上海阳帆医药科技有限公司 2016-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334927-A1 Nitroimidazole Compound, Preparation Method Therefor And Use Thereof In Drug Manufacturing NISCH, CYP51A1, CYP4F11 NR1H2 1945/4885ALDH1A1 610/4885GRM5 3934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.